Parameters | Healthy Donors Group two | Severe COVID-19 | Severe FLU A | Z | P | Z | P | Z | P |
---|---|---|---|---|---|---|---|---|---|
I | II | III | I:II | I:II | I:III | I:III | II:III | II:III | |
WBC(*109/L) median (IQR) | 6.05 (5.09,6.75) | 4.55 (2.70,6.93) | 5.99 (3.99,8.10) | 1.091 | 0.275 | 0.014 | 0.989 | 1.054 | 0.292 |
LY(*109/L) median (IQR) | 1.74 (1.41,2.04) | 0.81 (0.63,1.03) | 0.87 (0.56,1.42) | 3.219 | 0.001 | 5.616 | 0.000 | 0.154 | 0.878 |
T cell count (cells/mm3), median (IQR) | 1198 (1030,1507) | 461 (388,477) | 474 (357,747) | 3.29 | 0.001 | 6.848 | 0.000 | 0.505 | 0.613 |
CD4+ count (cells/mm3), median (IQR) | 645 (528,891) | 288 (202,329) | 283 (169,406) | 3.29 | 0.001 | 6.404 | 0.000 | 0.242 | 0.809 |
CD8+ count (cells/mm3), median (IQR) | 460 (363,716) | 144 (72,229) | 201 (138,305) | 3.147 | 0.002 | 5.900 | 0.000 | 1.296 | 0.195 |
CD4+/CD8+ ratio, median (IQR) | 1.43 (1.00,2.14) | 2.15 (0.96,5.09) | 1.32 (0.99,1.89) | 0.966 | 0.334 | 0.577 | 0.564 | 1.187 | 0.235 |